ZOOZ Strategy (Nasdaq: ZOOZ) clears Nasdaq minimum bid price warning
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
ZOOZ Strategy Ltd. reports that it has regained compliance with Nasdaq’s minimum bid price requirement. Nasdaq confirmed that for the 10 consecutive business days from June 1 to June 12, 2026, the closing bid price of ZOOZ’s ordinary shares was at or above $1.00 per share.
This closes a prior deficiency that began after the shares traded below $1.00 for 30 consecutive business days and had triggered a 180-day cure period ending June 15, 2026. Nasdaq has now formally notified the company that the bid price matter is closed and its listing under Rule 5550(a)(2) is in good standing.
Positive
- Nasdaq bid-price compliance restored: ZOOZ cured a prior deficiency under Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid of at least $1.00 for 10 consecutive business days, removing an immediate delisting risk tied to its share price.
Negative
- None.
Insights
ZOOZ removes a Nasdaq listing risk by curing its bid-price deficiency.
ZOOZ Strategy Ltd. had faced potential Nasdaq delisting after its shares closed below $1.00 for 30 straight business days, triggering a 180-day grace period to restore compliance with Nasdaq Listing Rule 5550(a)(2).
Nasdaq’s letter on June 15, 2026 confirms the bid price was at least $1.00 for 10 consecutive business days through June 12, 2026, officially closing the deficiency. This removes an overhang related to listing status and keeps the company eligible to use its existing Form S-8 and Form F-3 registration statements referenced in the report.
Key Figures
Minimum bid price threshold: $1.00 per share
Days below threshold: 30 consecutive business days
Cure period length: 180 calendar days
+3 more
6 metrics
Minimum bid price threshold
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) requirement
Days below threshold
30 consecutive business days
Period when shares closed below $1.00
Cure period length
180 calendar days
Compliance window ending June 15, 2026
Days at or above $1.00
10 consecutive business days
From June 1, 2026 to June 12, 2026
Initial Nasdaq notice date
December 16, 2025
Non-compliance notification
Compliance confirmation date
June 15, 2026
Nasdaq letter closing deficiency
Key Terms
Form 6-K, foreign private issuer, Nasdaq Listing Rule 5550(a)(2), minimum bid price requirement, +2 more
6 terms
Form 6-K regulatory
"This Report on Form 6-K and the information incorporated by reference"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Nasdaq Listing Rule 5550(a)(2) regulatory
"not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2)"
minimum bid price requirement financial
"not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2)"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Registration Statement on Form S-8 regulatory
"incorporated by reference into the Company’s Registration Statement on Form S-8, File No. 333-280741"
A registration statement on Form S-8 is the U.S. Securities and Exchange Commission filing companies use to register shares they intend to grant to employees, directors, consultants or benefit plans under stock compensation programs. It matters to investors because it signals potential issuance of new shares tied to pay and incentives, which can increase the total shares outstanding — like adding more slices to a pie — reducing each existing share’s ownership and potentially affecting earnings per share and stock value.
Registration Statements on Form F-3 regulatory
"into the Company’s Registration Statements on Form F-3, Files No. 333-288280, 333-288916, 333-289655, 333-290571 and 333-290638"
FAQ
What Nasdaq issue did ZOOZ Strategy Ltd. (ZOOZ) resolve in this 6-K?
ZOOZ Strategy Ltd. resolved a minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2). Its shares had previously closed below $1.00 for 30 straight business days, triggering a compliance period that is now successfully closed after meeting the price requirement.
What is Nasdaq’s minimum bid price requirement mentioned for ZOOZ (ZOOZ)?
Nasdaq’s minimum bid price requirement under Rule 5550(a)(2) requires a closing bid of at least $1.00 per share. ZOOZ had fallen below this level for 30 consecutive business days, then later maintained at least $1.00 for 10 consecutive business days to regain compliance.
How did ZOOZ Strategy Ltd. (ZOOZ) regain Nasdaq compliance by June 15, 2026?
ZOOZ regained compliance after Nasdaq determined that, from June 1 to June 12, 2026, its ordinary shares closed at or above $1.00 for 10 consecutive business days. This satisfied Nasdaq’s cure criteria before the June 15, 2026 deadline and closed the deficiency matter.
What was the 180-day cure period Nasdaq gave to ZOOZ (ZOOZ)?
Nasdaq granted ZOOZ a 180-calendar-day period, ending June 15, 2026, to restore its share price to the required level. During this window, the company needed to meet the $1.00 minimum bid price for a sufficient consecutive-day period, which it achieved by mid-June 2026.
Which registration statements does ZOOZ’s June 2026 6-K incorporate by reference?
The report incorporates by reference ZOOZ’s Registration Statement on Form S-8 (File No. 333-280741) and its Registration Statements on Form F-3 (File Nos. 333-288280, 333-288916, 333-289655, 333-290571, and 333-290638), linking this disclosure into those securities offerings.
What triggered Nasdaq’s original deficiency notice to ZOOZ Strategy Ltd. (ZOOZ)?
The original notice, dated December 16, 2025, was triggered when ZOOZ’s ordinary shares closed below $1.00 per share for 30 consecutive business days. This breach of Nasdaq Listing Rule 5550(a)(2) started the formal process that required the company to regain compliance.